Page 113 - ITPS-7-3

INNOSC Theranostics and
Pharmacological Sciences Alpha-2A receptor agonist and addiction

approaches for the treatment of drug addiction and craving. doi: 10.1007/s12035-011-8206-0
Curr Opin Pharmacol. 2005;5(1):107-118.
™
136. Hill E, Han D, Dumouchel P, et al. Long term Suboxone
doi: 10.1016/j.coph.2004.08.013 emotional reactivity as measured by automatic detection in
speech. PLoS One. 2013;8(7):e69043.
126. Mei W, Zhang JX, Xiao Z. Acute effects of sublingual
buprenorphine on brain responses to heroin-related cues doi: 10.1371/journal.pone.0069043. Erratum in: PLoS One.
in early-abstinent heroin addicts: An uncontrolled trial. 2013;8(8).
Neuroscience. 2010;170(3):808-815. doi: 10.1371/annotation/be0b3a26-c1bc-4d92-98c1-c516acc8dcf2
doi: 10.1016/j.neuroscience.2010.07.033 137. Bisaga A, Mannelli P, Sullivan MA, et al. Antagonists in the
127. Yücel M, Lubman DI, Harrison BJ, et al. A combined medical management of opioid use disorders: Historical and
spectroscopic and functional MRI investigation of the existing treatment strategies. Am J Addict. 2018;27(3):177-187.
dorsal anterior cingulate region in opioid addiction. Mol doi: 10.1111/ajad.12711
Psychiatry. 2007;12(7):611, 691-702.
138. Chalhoub RM, Kalivas PW. Non-opioid treatments for
doi: 10.1038/sj.mp.4001955 opioid use disorder: Rationales and data to date. Drugs.
128. De Ridder D, Vanneste S, Kovacs S, Sunaert S, Dom G. 2020;80(15):1509-1524.
Transient alcohol craving suppression by rTMS of dorsal doi: 10.1007/s40265-020-01373-1
anterior cingulate: An fMRI and LORETA EEG study.
Neurosci Lett. 2011;496(1):5-10. 139. Walsh SL, Gilson SF, Jasinski DR, et al. Buprenorphine
reduces cerebral glucose metabolism in polydrug abusers.
doi: 10.1016/j.neulet.2011.03.074 Neuropsychopharmacology. 1994;10(3):157-170.
129. Lin C, Karim HT, Pecina M, et al. Low-dose augmentation doi: 10.1038/npp.1994.18
with buprenorphine increases emotional reactivity but not 140. Dahlstroem A, Fuxe K. Evidence for the existence of
reward activity in treatment resistant mid- and late-life
depression. Neuroimage Clin. 2019;21:101679. monoamine-containing neurons in the central nervous
system. I. Demonstration of monoamines in the cell
doi: 10.1016/j.nicl.2019.101679 bodies of brain stem neurons. Acta Physiol Scand Suppl.
1964;Suppl 232:1-55.
130. Verdejo-García A, Lubman DI, Roffel K, et al.
Cingulate biochemistry in heroin users on substitution 141. Poe GR, Foote S, Eschenko O, et al. Locus coeruleus: A new
pharmacotherapy. Aust N Z J Psychiatry. 2013;47(3):244-249. look at the blue spot. Nat Rev Neurosci. 2020;21(11):644-659.
doi: 10.1177/0004867412463088 doi: 10.1038/s41583-020-0360-9
131. Seah S, Asad AB, Baumgartner R, et al. Investigation of 142. Valentino RJ, Van Bockstaele E. Convergent regulation of
cross-species translatability of pharmacological MRI in locus coeruleus activity as an adaptive response to stress.
awake nonhuman primate - a buprenorphine challenge Eur J Pharmacol. 2008;583(2-3):194-203.
study. PLoS One. 2014;9(10):e110432. doi: 10.1016/j.ejphar.2007.11.062
doi: 10.1371/journal.pone.0110432 143. Chandler DJ, Waterhouse BD, Gao WJ. New perspectives on

132. Nestler EJ. Reinforcement and addictive disorders. In: catecholaminergic regulation of executive circuits: Evidence
Molecular Neuropharmacology: A Foundation for Clinical for independent modulation of prefrontal functions by
Neuroscience. United States: McGraw Hill; 2009. midbrain dopaminergic and noradrenergic neurons. Front
Neural Circuits. 2014;8:53.
133. Hermann D, Frischknecht U, Heinrich M, et al. MR
spectroscopy in opioid maintenance therapy: Association of doi: 10.3389/fncir.2014.00053
glutamate with the number of previous withdrawals in the 144. Tjoumakaris SI, Rudoy C, Peoples J, Valentino RJ, Van Bockstaele
anterior cingulate cortex. Addict Biol. 2012;17(3):659-667. EJ. Cellular interactions between axon terminals containing
doi: 10.1111/j.1369-1600.2010.00290.x endogenous opioid peptides or corticotropin-releasing factor
in the rat locus coeruleus and surrounding dorsal pontine
134. Edwards D, Roy AK 3 , Boyett B, et al. Addiction by tegmentum. J Comp Neurol. 2003;466(4):445-456.
rd
any other name is still addiction: Embracing molecular
neurogenetic/epigenetic basis of reward deficiency. J Addict doi: 10.1002/cne.10893
Sci. 2020;6(1):1-4. 145. Valentino RJ, Wehby RG. Morphine effects on locus coeruleus
135. Blum K, Chen TJ, Bailey J, et al. Can the chronic neurons are dependent on the state of arousal and availability
administration of the combination of buprenorphine and of external stimuli: Studies in anesthetized and unanesthetized
naloxone block dopaminergic activity be causing anti-reward rats. J Pharmacol Exp Ther. 1988;244(3):1178-1186.
and relapse potential? Mol Neurobiol. 2011;44(3):250-268. 146. Curtis AL, Leiser SC, Snyder K, Valentino RJ. Predator stress

Volume 7 Issue 3 (2024) 19 doi: 10.36922/itps.1918